J. K. Choksi

Doxorubicin-induced congestive heart failure in adults

Mohamed M. Haq, Sewa S. Legha, J. K. Choksi et al. · Cancer · 1985 · 124 citations

Medicine, Oncology, Pharmacotherapy +12

Trebananib or placebo plus carboplatin and paclitaxel as first-line treatment for advanced ovarian cancer (TRINOVA-3/ENGOT-ov2/GOG-3001): a randomised, double-blind, phase 3 trial

Ignace Vergote, Giovanni Scambia, David M. O’Malley et al. · The Lancet Oncology · 2019 · 86 citations · Full text

Medicine, Gynecology, Oncology +11

Randomized Phase II Trial of Pemetrexed Combined With Either Cisplatin or Carboplatin in Untreated Extensive-Stage Small-Cell Lung Cancer

Mark A. Socinski, Charles Weissman, Lowell L. Hart et al. · Journal of Clinical Oncology · 2006 · 81 citations

Medicine, Oncology, Pharmacology +14

Randomized, Phase II Trial of Pemetrexed and Carboplatin with or without Enzastaurin versus Docetaxel and Carboplatin as First-Line Treatment of Patients with Stage IIIB/IV Non-small Cell Lung Cancer

Mark A. Socinski, Robert N. Raju, Thomas E. Stinchcombe et al. · Journal of Thoracic Oncology · 2010 · 34 citations · Full text

Medicine, Oncology, Pharmacology +13

Phase 2 Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin with Concurrent Radiation Therapy Followed by Pemetrexed Consolidation in Patients with Favorable-Prognosis Inoperable Stage IIIA/B Non–Small-Cell Lung Cancer

Hak Choy, Lee S. Schwartzberg, Shaker R. Dakhil et al. · Journal of Thoracic Oncology · 2013 · 33 citations · Full text

Medicine, Oncology, Radiation Oncology +16